UK becomes first in Europe to approve oral GLP-1 weight-loss medication for adults with obesity and type 2 diabetes

The UK has approved orforglipron, a new once-daily oral medication for weight management and type 2 diabetes, marking a first in Europe. The drug offers a convenient alternative to existing treatments and is subject to NHS evaluation before wider availability.…













